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Bone has the capacity to regenerate and not scar after injury – sometimes leaving behind
no evidence at all of a prior fracture. As surgeons capable of facilitating such healing, it
becomes our responsibility to help choose a treatment that minimizes functional deficits
and residual symptoms. And in the case of the geriatric hip fracture, we have seen the
accumulation of a vast amount of evidence to help guide us.The best method we currently
have for selecting treatment plans is by the practice of evidence-based medicine. Accord-
ing to the now accepted hierarchy, the best is called Level I evidence (e.g., well performed
randomized controlled trials) – but this evidence is best only if it is available and appropri-
ate. Lower forms of accepted evidence include cohort studies, case control studies, case
series, and case reports, and last, expert opinion – all of which can be potentially instruc-
tive. The hallmark of evidence-based treatment is not so much the reliance on evidence in
general, but to use the best available evidence relative to the particular patient, the clinical
setting and surgeon experience. Correctly applied, varying forms of evidence each have a
role in aiding surgeons offer appropriate care for their patients – to help them best fix the
fracture.
Keywords: fracture, orthopedic trauma, evidence-based medicine, surgical decision making, level of evidence,
expert opinion, collective intelligence
INTRODUCTION
The management of fragility hip fractures, now 300,000 plus in the
US yearly, may seem superficially to be among the most studied
and settled questions in orthopedic surgery: even the geographic
variations in incidence of operative management of fragility hip
fractures show low variation (1). Many surgeons appear to agree
with the mantra voiced in the Internet video, Orthopedics vs.
Anesthesia (2): “There is a fracture; I need to fix it.”
Yet even if we accept that fragility fractures of the hip should be
treated surgically, numerous questions remain. Which procedure
is best: joint replacement or fixation? If replacement is chosen,
should it be total or hemiarthroplasty? Which surgical approach is
better? Should the implant be cemented? And how soon should the
patient be taken to the operating room? (Figure 1). These ques-
tions are not always easy to answer for the single patient that you
are confronted with. Nonetheless, they can be addressed rationally
with the tools of evidence-based medicine.
The purpose of this presentation is to illustrate the methods
(and limitations) of the evidence-based medicine approach in the
management of fragility hip fractures.
The commonly quoted definition is attributed to Sackett (3):
“Evidence-based medicine is the conscientious, explicit, and judi-
cious use of current best evidence in making decisions about
the care of individual patients. The practice of evidence-based
medicine means integrating individual clinical expertise with
the best available external clinical evidence from systematic
research.”
This assumes that physicians’ decisions should rely on evidence
of the highest quality. Accordingly “levels of evidence” hierarchies
have been devised, the essence of which “is that, in general, con-
trolled studies are better than uncontrolled studies, prospective
studies are better than retrospective studies, and randomized stud-
ies are better than non-randomized studies” (4). Nevertheless, the
practice of evidence-based medicine is more than simply applying
the highest-level evidence: there are many reasons to not wor-
ship exclusively at the altar of randomized controlled trials. For
instance, there are very few such trials in the orthopedic surgery
literature. Obremskey et al. (5) reviewed 382 articles published in
nine orthopedic journals and found that level I studies comprised
11.3% of the sample.
Also, randomized controlled studies can be misleading; lower
level studies can be informative; expert opinion is inextricably
tied to the evaluation and implementation of evidence; useful
information may be found in places not even on the evidence hier-
archy; perfect information about treatment options and outcomes
is insufficient.
RANDOMIZED CONTROLLED TRIALS
The prospective, double-blinded randomized controlled trial is
the most powerful design to avoid biases (and ultimately wrong
conclusions).
• When a study is defined prospectively, the researcher will be
aware of, and required to explain, subject drop out rates, lost to
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FIGURE 1 |This diagram represents the potential treatment options for a
displaced femoral neck fracture with discrete nodes of decision making,
which proceeds from top to bottom. Despite attempts to make the process
rational, e.g., “if fracture is displaced and the patient is elderly, consider
arthroplasty instead of fixation,” other considerations may lead the surgeon
from one treatment option to another (curved arrows). For instance, a
60-year-old patient with a valgus impacted fracture may initially be considered
for fixation. At the other extreme, if the patient has pre-existing hip arthritis
and is an active community ambulatory with minimal medical risk factors,
even a non-displaced fracture may do better with total hip replacement.
follow-up status, or failure of subjects to receive the treatment
they were assigned to receive.
• When the study is “double blinded,” neither the subjects nor the
examiner knows which treatment the subject got and thus helps
avoid patients’ or surgeons’ aspirations coloring the outcomes.
• Randomization refers to the allocation of subjects to groups
according to a purely chance process. A pure experiment would
expose two cohorts of identical subjects to identical stimuli but
for the item of interest. Because that cannot happen outside of
the laboratory, the random allocation of a large number of sub-
jects is used to ensure that our groups are as equal as possible,
especially with regard to feature whose importance is unknown.
• The use of a control group allows one to state the relative efficacy
of the intervention. For example, one recent study (6) reported
that approximately 50% of patients whose pertrochanteric
hip fracture was treated with an intramedullary nail were, at
6 months, using the same walking aids employed before they
fell. In the abstract, it might be hard to say whether this is a
good result or not. The contrast provided by comparator group,
namely, the 40% rate in the group treated with a sliding screw,
allows us to make a more meaningful inference.
Therefore, well-designed and performed randomized trials can
provide the most meaningful conclusions for specific treatment
questions posed. However, not all randomized controlled trials
are the highest-level of evidence. Consider a recent multicenter
randomized controlled trial in which reduction and fixation was
compared with bipolar hemiarthroplasty and total hip replace-
ment. In this study, 298 patients were randomized to one of the
treatments. Nonetheless, this study was deemed by the Journal in
which it appeared to be a level-II study, owing to the fact that
the follow-up data were obtained from fewer than 80% of those
enrolled. In addition, a summary statistic from a RCT may not
apply to your patient (who may never have met inclusion criteria
for the study). Larger studies that are able to stratify based on sec-
ondary independent variables of interest (e.g., active heart disease
or age greater than 85) can help determine whether the conclusions
apply to your particular population, though such sub-group analy-
ses must be carefully interpreted (7). Indeed, an understanding of
how similar or dissimilar your patient is to the trial population
will help you properly apply the study results.
Because some trials are better than others, the best evidence is
obtained from pooled analyses of trials, yet even that can come up
short. Hopley et al. (8), in an effort to determine whether total hip
arthroplasty was superior to hemiarthroplasty for fragility frac-
tures of the hip, performed a systematic review and meta-analysis
of four randomized controlled trials, three “quasi-randomized”
trials, and eight retrospective cohort studies. Their data showed
that total hip arthroplasty offers a lower risk of reoperation and
better ratings in the Harris hip score at the price of slightly higher
risk of dislocation and general complications, exactly the sort of
information they sought. But even with pooling these 15 stud-
ies, they were forced to add that “with an overall sample size
[from all of the studies] of fewer than 2000 patients our results
do not allow for conclusive statements on the effectiveness of total
hip arthroplasty and hemiarthroplasty for treating femoral neck
fractures.”
MID-LEVEL EVIDENCE
By every measure, as detailed above, high-level evidence (e.g.,
from randomized trials) is better than mid-level evidence (e.g.,
from cohort studies or cases series). Nevertheless, these mid-level
sources of evidence play an important role in the practice of
evidence-based medicine, chiefly because high-level evidence is
so rare. Brooke et al. (9), for example, in their study of trends
in the quality of highly cited surgical research, found that despite
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improvements over the years only approximately 40% of their
sample of highly cited recent papers employed high quality evi-
dence. Beyond that, lower levels of evidence – which are more
likely to highlight adverse events – can be powerful modulators of
the “good news” that emanates from prospective trials. After all, as
Popper noted, it takes only one black swan to refute the assertion
“All swans are white.”
The lack of high quality evidence is not an indictment of
researchers; sometimes mid-level evidence is best. Consider how
the dangers of smoking were detected. No study took 10,000 twins,
forced 5,000 of them to smoke on a regular basis for 40 years and
thereafter assessed the rate of lung cancer in the two groups. Con-
strained by practicality, the toxic effect of cigarette smoke was
found by case–control methods: studies looked at groups of people
who currently have lung cancer (cases) or do not have it (controls),
and assessed whether there was a higher rate of cigarette smoking
in the lung cancer group. It is just not feasible to run a trial over
four decades or to force a potentially detrimental“treatment”upon
patients.
Ideally, evaluation of a novel surgical intervention will have a
control group; and when the outcome is pain relief, the addition
of a sham control group would be even better (The addition of a
sham group will quantify the “placebo effect,” namely the positive
change in symptoms that are related to a participant’s perceptions
of their treatment rather than to the mechanisms of the treatment
itself.). However, while randomization is a powerful tool in study
design, it is not always feasible or ethical to proceed with a random-
ized, controlled trial. For example, while theory would suggest that
the timing of operative debridement of an open fracture wound
is best determined with a randomized trial, it is unacceptable to
mandate that patients with open fractures suffer an unnecessary
delay in their treatment simply because they were randomized to
that treatment arm.
Observational designs can be useful tools when outcomes are
rare rendering clinical trials too costly and too inefficient to answer
a question in a timely manner. Most randomized trials fall victim
to so-called Type II error (namely, false negative findings), simply
due to an inability to recruit enough patients. On average, surgical
trials are 1/10th the size needed to confirm important treatment
effects.
A “differential expertise bias” is inherent in most, if not all,
studies in orthopedic surgery involving surgical treatment. This is
a particular concern when subjects are randomized between two
groups and the skill with which they are treated may vary accord-
ing to their randomization, either because the surgeon may not be
equally adept with both techniques, or because different surgeons
are used in the different treating arms of the study [In one study
(10) comparing internal fixation, bipolar hemiarthroplasty, and
total hip arthroplasty for the management of displaced subcapital
fracture of the hip, consultants were twofold more likely to per-
form the surgery than trainees when the patient was assigned to a
“replacement” treatment vs. fixation.].
EXPERTS AND EXPERTISE
Although the levels of evidence hierarchy suggests that evidence
is improved the more it is resistant to human biases, the role of
experts and importance of expertise is central to the practice of
evidence-based medicine. Bear in mind that clinical studies are not
the findings of naturalists, collecting observations on pure biolog-
ical phenomena; they are the answers to questions posed by people
(researchers) recording the effects of interventions created by peo-
ple (inventors) and practiced by people (surgeons) in the service
of other people (patients). That is, the questions addressed in clin-
ical papers are the questions defined by the experts; the treatments
under scrutiny are the treatments devised and implemented by
experts. The role of experts cannot be excised.
Furthermore, and perhaps no less importantly, clinical stud-
ies are read and employed only to guide the application of one’s
individual skills, i.e., personal expertise. Consider that one study
in the literature (11) has suggested that there are more disloca-
tions of hip hemiarthroplasties inserted via the posterior approach
as compared to the direct lateral route. This study of 2906 pri-
mary hemiarthroplasties found that “the overall dislocation rate
for the posterior approach was 9.0% (149/1656), whereas that for
the direct lateral approach was 3.3% (41/2150).” Omitting for a
moment that the Cochrane review (12) on this topic stated that
there is “currently insufficient evidence from randomized trials
to determine the optimum surgical approach for insertion of a
hemiarthroplasty to the hip,” it still is the case that at least in
one specific circumstance the posterior approach is unequivocally
superior: namely, when the surgeon who is asked to apply the evi-
dence – i.e., perform the surgery – is proficient with the posterior
approach and inept with the lateral. In that instance, it would be
unequivocally incorrect for the surgeon to use an approach he
has not mastered, regardless of what the literature has to say (The
“correct” course of action, on the other hand is quite, equivocal.
Should the surgeon examine her own dislocation rate and pro-
ceed if lower than 9.0%? Should the patient’s care be transferred
to another surgeon who specializes in arthroplasty? How much
does the patient need to know to make an informed decision? All
interesting questions but beyond the scope of this manuscript.)
Overall, the literature can at best inform the reader, which of
the available choices is optimal; and if what the literature suggests
is not available – because of the reader’s particular expertise or
lack thereof – then clearly some other solution must be applied.
The appraisal of evidence also relies on expertise. Recall that
“the probability that a research finding is indeed true” (13) is not
merely a function of the power of the study or the level of statistical
significance of its results but also “the prior probability of it being
true (before doing the study).” In that regard, a clinical study is
like a diagnostic test. Just as the results of diagnostic test trans-
form a pre-test probability of disease into a post-test probability,
the results of clinical study transforms the prior truth probability
of whatever the study asserts into a post study probability – the
“new” truth probability.
Hence, because studies can be falsely negative or falsely posi-
tive, findings should not be accepted as canonical facts; rather, a
study simply changes the likelihood that what it found is actually
true. (Just think: if this assertion were wrong, there would be no
need for journal clubs – what is there to discuss, if all findings are
simply accepted as true?)
Consider a recent study (14) that examined 116 patients with an
acute displaced femoral neck fracture. These patients were treated
with either a cemented or an uncemented hemiarthroplasty and
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assessed for pain, mortality, mobility, and complications among
other measures. Overall, the authors found that complication rates
were lower in the group treated with a cemented implant and that
better function and better mobility in the cemented group was
suggested as well. The question remains, Should a surgeon use
cement? In essence that can be translated to, “What is the prob-
ability that a research finding – that cementing is superior – is
indeed true?”
The probability that cementing is superior, after considering
this study, depends on two factors: how good the study was and
how likely it was – before the study was done – that cementing
was indeed superior. The first factor requires contemplation of
potential biases and errors in the study, and the nature (level) of
the evidence at hand. One must scrutinize the study with all of
the tools of evidence-based medicine and make some assessment
that the study as described would possibly produce false negative
or false positive results. Yet the ultimate truth-value of the study
depends also on the reader’s pre-test probability assessment of the
results. And at some point, that prior probability is based on expert
opinion – if not one’s own, than of one’s teachers, or of textbooks
and the like. Medical literature cannot be interpreted without any
idea of prior probability. A mere change of the prior probability
from 20 to 30% determines whether the study’s findings are more
likely than not to be true. And these probabilities must rest at least
in part on expert opinion.
NEW FORMS OF EVIDENCE
The diagnosis of a displacement of a femoral neck fracture seems
to be straightforward. Nevertheless, this is a diagnosis that is made
with far from perfect accuracy. Two studies examining the accu-
racy of displacement of femoral neck fractures implicitly found
that at least 15% of cases were mislabeled. These studies, it should
be pointed out, did not set out to measure accuracy, but rather
reliability. However, while reliability is not equivalent to accuracy,
it is a necessary condition for it. One could not be consistently
accurate without being consistent in general.
A reliability analysis regarding a binary feature (e.g., displace-
ment) can also provide an upper bound on the average accuracy
of the two viewers. That is because when two surgeons disagree
about displacement, one of them must be wrong. Accordingly,
each instance of disagreement represents one error (out of the two
paired observations) and as such the square root of the agreement
rate is an approximate upper bound on the average accuracy. Thus,
when Oakes et al. (15) report an agreement level of 0.73 value, and
a 0.68 value was determined by Thomsen et al. (16), the square
root of these kappa values suggests an upper bound on the accu-
racy rate in the range of 82–85%. Given that some surgeons believe
that treatment choice is driven by the presence or absence of dis-
placement, this rate might be too high. The question is what to do
about it.
One proposed approach centers on the observation that if
errors are random, chance events, then greater reliability (and in
turn greater accuracy) might result from having multiple readers
(17). In a recent study, displacement reliability was assessed for
lone readers, but also for random groups of three or five read-
ers, with the verdict on displacement governed simply by majority
rules. These groups did indeed have higher reliability: whereas
the lone readers had an agreement rate of 0.69, the three and five
member groups had a kappa of 0.77 and 0.80, respectively.
The amalgamation of a consensus diagnosis (now perhaps
more feasible given the ubiquity of networked smart-phones and
digital radiography) is a form of crowd intelligence. Crowd intelli-
gence was first suggested by Galton (18), who noted that although
butchers were more accurate than random people at guessing the
weight of an ox, the mean estimate of a crowd of such ordinary
people was closer to the measured weight than any individual
expert’s response. (A more contemporary example is that of all
of the “lifelines” employed on the TV show, who wants to be a
millionaire, asking the audience for a consensus guess is the most
helpful.)
Crowd intelligence can go beyond requesting diagnoses from
members of a group. One hint at this new form of evidence comes
from a report in Nature (19) that the onset of a flu epidemic might
be detected by an increased frequency of searches on Google for
flu remedies. As more and more patient information is stored
in electronic records – and with additional information noted in
registries and insurance data bases (among other sites) – it is pos-
sible that the mining these sources will produce a mother lode
of worthwhile information – information that does not quite fit
on the evidence hierarchy today, but may nonetheless help guide
patient care.
BEYOND MEDICAL EVIDENCE
The hierarchy of medical evidence places randomized control
trials at the top, but even armed with evidence from relevant ran-
domized controlled trials one is not fully informed about which
treatment option is best. That is because the medical literature
provides only the list of possible treatment options for a given
problem, the possible outcomes from those treatments, and the
probability of reaching these outcomes. Such a collection of infor-
mation, formidable though it is, is not enough to make a decision,
as explained.
Medical decision making is based on a so-called expected value
decision analysis. The expected value of a treatment option is the
sum of the values of each possible outcome that may result from
employing that option, each multiplied by the likelihood that
the given outcome will be found (Values are typically expressed
as “utility” points, a common currency that allows comparison
between disparate entities. It need not consider monetary value at
all, but it can, if financial considerations matter to those who are
expressing their utilities.).
Thus, if one knows how much each outcome is worth, and
knows the likelihood that each outcome could be attained, one
can measure the value of each option. Accordingly, picking the best
option is simply choosing the one with the highest expected util-
ity. Figure 2 shows a decision tree representing a very simplified
synopsis of the options and possible outcomes when consider-
ing the treatment of a displaced femoral neck fracture. In this
model shown, the patient is given the choice of either fracture
fixation or joint replacement, each of which has (in this simpli-
fied example) one possible complication: the operation will fail
and second operation will be needed. In this model, the util-
ity value of ORIF is [(probability of success of ORIF)× (value
of success of ORIF)+ (probability of failure of ORIF)× (value
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FIGURE 2 | A simplified decision tree, showing two options (shown in
blue and yellow), each leading, in turn to either a “good” (green) or
“bad” (red) outcome. The probabilities of reaching each outcome are given
but p i and the values by u i.
of failure of ORIF)]. Similarly, the utility value of arthoplasty
is [(probability of success of arthoplasty)× (value of success of
arthoplasty)+ (probability of failure of arthoplasty)× (value of
failure of arthoplasty)].
With that equation in hand, one sees that even if we stipulate
that the rate of revision operations is 10 times higher with fixa-
tion operations (20) (42 vs. 4%) we cannot state that fixation is
the inferior choice. That is because for some particular patient,
the value of a successful fixation operation may exceed the value
of a successful arthroplasty by sufficient margin to make fixation
preferable.
Imagine a patient assigns a utility value of 100 to successful
fixation and 60 points to a successful arthroplasty (and for sim-
plicity, we can assume that the value of the complication state is
zero for both choices, allowing that term to drop out; without
this assumption the math becomes a bit more complicated but
the point still holds). If there is a 58% of attaining success with
ORIF, then the value of this option is (100× 0.58)+ (0× 0.42),
i.e., 58 utility points. For arthroplasty, the expected utility is
(60× 0.96)+ (0× 0.04) or 57.8 points.
A surgeon practicing evidence-based medicine cannot impose
his or her values on the patient, but rather must attempt (21) to
discern the patient’s own values. This exercise is not easy, to be sure,
as patients may not be able to express their values clearly (22), or
for that matter, even hold consistent values. It may be, for exam-
ple, that ORIF is deemed preferable when the patient considers its
potential for success, but when the choice is framed (23) in terms
of avoiding complications, a natural aversion for avoiding loss
may make the arthroplasty option more appealing. To date, this
dilemma – how to assess and apply patient preferences – remains
unsolved.
CONCLUDING REMARKS
The management of fragility fractures of the hip follows rule that
are perhaps easy to state, but perhaps not so easily applied. We
can agree that patients must be taken to the operating room as
soon as possible – but how soon is that? We might agree that dis-
placed fractures should be treated with joint replacement, but we
might not agree that a given fracture is displaced. We can agree
on the theoretical superiority of a particular technique, method
or approach, but we also agree that a particular surgeon managing
a particular case should be granted broad deference to his judg-
ment and skills. For instance, a cemented total hip replacement
inserted via the lateral approach might be most reliable, unless the
surgeon is more proficient at some other technique. And we all
agree that surgeons must respect patients’ autonomous decisions,
even if our tools for discerning patient preferences are imperfect
at best.
It may be tempting to shift the uncertainty upstream – to strive
to make the best decisions to help prevent the fracture in the
first place and thereby avoid the dilemmas associated with treat-
ment. Then again, the area of prevention, too, is fraught with
its own decision making dilemmas. Whitaker et al. (24) recently
noted that “the optimal duration of use [of medications to pre-
vent osteoporosis] has not been determined. Decisions to continue
treatment must be based on individual assessment of risks and
benefits and on patient preference. Further investigation into the
benefits and risks of long-term therapy. . .will be crucial for deter-
mining the best regimen of treatment for individual patients with
osteoporosis.”
With that in hand, we would be wise to emphasize the first
clause of Sackett’s definition“The practice of evidence-based med-
icine means integrating individual clinical expertise with the best
available external clinical evidence from systematic research.” In
the end, the practice of medicine relies as much on individual clin-
ical expertise – the art of medicine – as it does numbers, data and
study conclusions. Improving the quality and quantity of clin-
ical evidence collected – only when combined with improving
the education and expertise of practitioners in applying that evi-
dence – will lead to better surgical decision making and thereby
inform us how best to fix the fracture.
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